z-logo
open-access-imgOpen Access
Administration of the Interleukin-1 Inhibitor Canakinumab in Children with Autoinflammatory Diseases and Systemic Juvenile Arthritis: the Report for Case Series
Author(s) -
С О Салугина,
М. I. Kaleda,
Ye. S. Fyodorov,
И. П. Никишина
Publication year - 2016
Publication title -
вопросы современной педиатрии
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.12
H-Index - 5
eISSN - 1682-5535
pISSN - 1682-5527
DOI - 10.15690/vsp.v15i1.1504
Subject(s) - canakinumab , medicine , tolerability , anakinra , arthritis , dermatology , adverse effect , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom